Answers are grounded in this paper and cite their sources.
High Resolution Image Download MS PowerPoint Slide Nearly 10 years ago, Frank Gupton and I had a chance encounter where we learned that we both had interest in creating efficient routes to generic medicines. Lucky for me, Frank and I began mentoring each other—Frank teaching me wisdom gained from 30 years in industry and I sharing what I knew about the academic world. As some who know Frank will understand, his lessons in some cases seem devilishly obvious and should be chanted daily like a zen koan while others are subtle and complex, requiring many years of reflection. Frank was asked by OPR&D to offer these lessons in a condensed form so that others might learn what I have. Frank and I decided that a transcript of our many conversations condensed into one document might do the trick.
No takes yet. Share an insight, caveat, or question.
Gupton et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: